NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1039 coverClinical and Basic Oculomotor Research: In Honor of David S. Zee Volume 1039 published April 2005
Ann. N.Y. Acad. Sci. 1039: 528–531 (2005). doi: 10.1196/annals.1325.060
Copyright © 2005 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by GLASAUER, S.
Articles by BRANDT, T.
Search for Related Content
PubMed
PubMed Citation
Articles by GLASAUER, S.
Articles by BRANDT, T.
Effect of 4-Aminopyridine on Upbeat and Downbeat Nystagmus Elucidates the Mechanism of Downbeat Nystagmus

STEFAN GLASAUER, MICHAEL STRUPP, ROGER KALLA, ULRICH BÜTTNER AND THOMAS BRANDT

Center for Sensorimotor Research, Department of Neurology, Ludwig-Maximilian-University, D-81377 Munich, Germany

Address for correspondence: Stefan Glasauer, Zentrum für Sensomotorik, Klinikum Großhadern, Marchioninistr. 23, D-81377 München, Germany. Voice: +0049-89-7095-4839; fax: +0049-89-7095-4805. sglasauer{at}nefo.med.uni-muenchen.de

The potassium channel blocker 4-aminopyridine (4-AP) restored vertical smooth pursuit and gaze holding in light in one patient with upbeat (UBN) and in one with downbeat nystagmus (DBN). Without a visible target, however, 4-AP had no effect on UBN, but DBN vanished. We hypothesize that this difference in the effects of 4-AP, which is known to increase the excitability of cerebellar Purkinje cells, can be attributed to the different lesion sites involved in UBN and DBN.

Key Words: patient • cerebellum • potassium channel blocker




This article has been cited by other articles:


Home page
NeurologyHome page
K. Hufner, T. Stephan, R. Kalla, A. Deutschlander, J. Wagner, M. Holtmannspotter, G. Schulte-Altedorneburg, M. Strupp, T. Brandt, and S. Glasauer
Structural and functional MRIs disclose cerebellar pathologies in idiopathic downbeat nystagmus
Neurology, September 11, 2007; 69(11): 1128 - 1135.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. Kalla, S. Glasauer, U. Buttner, T. Brandt, and M. Strupp
4-Aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus
Brain, September 1, 2007; 130(9): 2441 - 2451.
[Abstract] [Full Text] [PDF]



footerLeft footerRight